Blood Monocyte Frequency May Be a Biomarker for Response to Anti-PD-1 [Research Watch]

CD14⁺CD16^–HLA-DR^hi monocyte frequency was linked to response to anti–PD-1 in patients with melanoma.

from Cancer via ola Kala on Inoreader http://ift.tt/2Ed3n0h
via IFTTT